Summary
A combination of Southern blotting and the analysis of polymerase chain reaction (PCR) amplified DNA fragments was used to screen the factor VIII genes of 527 haemophilia A patients for point mutations within TaqI restriction sites. Since this “directed search” strategy yielded only four gene lesions, it was concluded that its efficacy is less than that originally predicted. One novel point mutation was however found in a moderately severe haemophiliac; a CGA (Arg) to CTA (Leu) transversion at codon 2209, an evolutionarily conserved residue in the C2 domain of the factor VIII protein. The remaining three detected lesions, CGA (Arg)→TGA (Term) transitions at codons 2116, 2147 and 2307, respectively, have been reported before and are consistent with recurrent mutation at these hypermutable sites. A number of TaqI restriction site polymorphisms/rare variants were also noted. These variants appear to be population-specific but are nevertheless potentially useful in individual cases as intragenic markers for carrier detection and antenatal diagnosis.
Similar content being viewed by others
References
Antonarakis SE, Waber PG, Kittur SD, Patel AS, Kazazian HH, Mellis MA, Counts RB, Stamatoyannopoulos G, Bowie EJW, Fass DN, Pittman DD, Wozney JM, Toole JJ (1985) Hemophilia A: detection of molecular defects and of carriers by DNA analysis. N Engl J Med 313:842–848
Antonarakis SE, Youssoufian H, Kazazian HH Jr (1987) Molecular genetics of hemophilia A in man. Mol Biol Med 4:81–94
Barker D, Schafer M, White R (1984) Restriction sites containing CpG show a higher frequency of polymorphism in human DNA. Cell 36:131–138
Barrowcliffe TW (1984) Comparison of one-stage and two-stage assays of factor VIII:C. Scand J Haematol [Suppl] 41:39–54
Bernardi F, Legnani C, Volinia S, Patracchini P, Rodorigo G, DeRosa V, Marchetti G (1988) A HindIII RFLP and a gene lesion in the coagulation factor VIII gene. Hum Genet 78:359–362
Bernardi F, Volinia S, Patracchini P, Gemmati D, Boninsegna S, Schwienbacher C, Marchetti G (1989) A recurrent missense mutation (Arg→Gln) and a partial deletion in factor VIII gene causing severe haemophilia A. Br J Haematol 71:271–276
Casula L, Murru S, Pecorara M, Ristaldi MS, Restagno G, Mancuso G, Morfini M, DeBiasi R, Baudo F, Carbonara A, Mori PG, Cao A, Pirastu M (1990) Recurrent mutations and three novel rearrangements in the factor VIII gene of hemophilia A patients of Italian descent. Blood 75:662–670
Cooper DN, Krawczak M (1989) Cytosine methylation and the fate of CpG dinucleotides in vertebrate genomes. Hum Genet 83:181–188
Cooper DN, Krawczak M (1990) The mutational spectrum of single base-pair substitutions causing human genetic disease: patterns and predictions. Hum Genet 85:55–74
Cooper DN, Youssoufian H (1988) The CpG dinucleotide and human genetic disease. Hum Genet 78:151–155
Cooper DN, Smith BA, Cooke HJ, Niemann S, Schmidtke J (1985) An estimate of unique DNA sequence heterozygosity in the human genome. Hum Genet 69:201–205
Duncan BK, Miller JH (1980) Mutagenic deamination of cytosine residues in DNA. Nature 287:560–561
Foster PA, Fulcher CA, Houghten RA, Zimmerman TS (1990) Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine. Blood 75:1999–2004
Gitschier J, Wood WI, Goralka TM, Wion KL, Chen EY, Eaton DH, Vehar GA, Capon DJ, Lawn RM (1984) Characterization of the human factor VIII gene. Nature 312:326–330
Gitschier J, Wood WI, Tuddenham EGD, Shuman MA, Goralka TM, Chen EY, Lawn RM (1985) Detection and sequence of mutations in the factor VIII gene of haemophiliacs. Nature 315:427–430
Gitschier J, Wood WI, Shuman MA, Lawn RM (1986) Identification of a missense mutation in the factor VIII gene of a mild haemophiliac. Science 232:1415–1416
Green PM, Bentley DR, Mibashan RS, Nilsson IM, Giannelli F (1989) Molecular pathology of haemophilia B. EMBO J 8:1067–1072
Higuchi M, Kochhan L, Schwaab R, Egli H, Brackmann H-H, Horst J, Olek K (1989) Molecular defects in hemophilia A: identification and characterization of mutations in the factor VIII gene and family analysis. Blood 74:1045–1051
Hill AVS, Wainscoat JS (1986) The evolution of the alphaand beta-globin gene clusters in human populations. Hum Genet 74:16–23
Inaba H, Fujimaki M, Kazazian HH Jr, Antonarakis SE (1989) Mild hemophilia A resulting from an Arg-to-Leu substitution in exon 26 of the factor VIII gene. Hum Genet 81:335–338
Kane WH, Davie EW (1988) Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. Blood 71:539–555
Kazazian HH Jr, Wong C, Youssoufian H, Scott AF, Phillips DG, Antonarakis SE (1988) Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature 332:164–166
Levinson B, Janco R, Phillips J, Gitschier J (1987) A novel missense mutation in the factor VIII gene identified by analysis of amplified haemophilia DNA sequences. Nucleic Acids Res 15:9797–9805
Levinson B, Lehesjoki A-E, Chapelle A de la, Gitschier J (1990) Molecular analysis of hemophilia A mutations in the Finnish population. Am J Hum Genet 46:53–62
Mikami S, Nishimura T, Naka H, Kuze K, Fukui H, Tone M, Hashimoto-Gotoh T (1988) Nonsense mutation in factor VIII gene of a severe haemophiliac patient with anti-factor VIII antibody. Jpn J Hum Genet 33:409–415
Millar DS, Steinbrecher RA, Wieland K, Grundy CB, Martinowitz U, Krawczak M, Zoll B, Whitmore D, Stephenson J, Mibashan RS, Kakkar VV, Cooper DN (1990) The molecular genetic analysis of haemophilia A; characterization of six partial deletions in the factor VIII gene. Hum Genet 86:219–227
Nussinov R (1981) Eukaryotic dinucleotide preference rules and their implications for degenerate codon usage. J Mol Biol 149:125–131
Pattinson JK, Millar DS, McVey JH, Grundy CB, Wieland K, Mibashan RS, Martinowitz U, Tan-Un K, Vidaud M, Goossens M, Sampietro M, Mannucci PM, Krawczak M, Reiss J, Zoll B, Whitmore D, Bowcock S, Wensley R, Ajani A, Mitchell V, Rizza C, Maia R, Winter P, Mayne EE, Schwartz M, Green PJ, Kakkar VV, Tuddenham EGD, Cooper DN (1990) The olecular genetic analysis of hemophilia A; a directed search strategy for the detection of point mutations in the human factor VIII gene. Blood 76:2242–2248
Rotblat F, Tuddenham EGD (1981) Immunological studies of factor VIII coagulant activity (VIII:C). 1. Assays based on a haemophilic and an acquired antibody to VIII:C. Thromb Res 21:431–445
Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491
Stubbs JD, Lekutis C, Singer KL, Bui A, Yuzuki D, Srinivasan U, Parry G (1990) cDNA cloning of a mouse mammary epithelial cell surface protein reveals the existence of epidermal growth factor-like domains linked to factor VIII-like sequences. Proc Natl Acad Sci USA 87:8417–8421
Toole JJ, Knopf JF, Wozney JM, Sultzman LA, Buecker JL, Pittman DD, Kaufman RJ, Brown E, Shoemaker C, Orr EC, Amphlett GW, Foster WB, Coe ML, Knutson GJ, Fass DN, Hewick RM (1984) Molecular cloning of a cDNA encoding human anti-haemophilic factor. Nature 312:342–347
Traystman MD, Higuchi M, Kasper CK, Antonarakis SE, Kazazian HH Jr (1990) Use of denaturing gradient gel electrophoresis to detect point mutation in the factor VIII gene. Genomics 6:293–301
Tuddenham EGD (1989) Factor VIII and haemophilia A. Baillieres Clin Haematol 2:849–877
Vehar GA, Keyt B, Eaton D, Rodriguez H, O'Brien DP, Rotblat F, Oppermann H, Keck R, Wood WI, Harkins RN, Tuddenham EGD, Lawn RM, Capon DJ (1984) Structure of human factor VIII. Nature 312:337–342
Walker FJ, Scandella D, Fay PJ (1990) Identification of the binding site for activated protein C on the light chain of factors V and VIII. J Biol Chem 265:1484–1489
Youssoufian H, Kazazian HH Jr, Phillips DG, Aronis S, Tsiftis G, Brown VE, Antonarakis SE (1986) Recurrent mutations in haemophilia A give evidence for CpG mutation hotspots. Nature 324:380–382
Youssoufian H, Antonarakis SE, Bell W, Griffin AM, Kazazian HH Jr (1988a) Nonsense and missense mutations in hemophilia A: estimate of the relative mutation rate at CG dinucleotides. Am J Hum Genet 42:718–725
Youssoufian H, Kazazian HH, Patel A, Aronis S, Tsiftis G, Hoyer LW, Antonarakis SE (1988b) Mild hemophilia A associated with a cryptic donor splice site mutation in intron 4 of the factor VIII gene. Genomics 2:32–36
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Millar, D.S., Zoll, B., Martinowitz, U. et al. The molecular genetics of haemophilia A: screening for point mutations in the factor VIII gene using the restriction enzyme TaqI. Hum Genet 87, 607–612 (1991). https://doi.org/10.1007/BF00209022
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00209022